SRPT in the 13F filings
Sarepta Therapeutics Inc · CUSIP 803607100
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 25
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 5 listed it in both
- Shares listed
- 17,804,138
- combined, among listed positions
- Reported value
- $320m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 14 buyers (opened or added shares) and 16 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,596,731.
Managers listing SRPT in Q2 2026
25 of 25 holders
Largest increases and reductions, by shares
Increases
- Marshall Wace LLPexisting position · 2,206,022 shares now+1,480,954
- Point72 Asset Management LPnew position · 510,908 shares now+510,908
- Invesco Ltdexisting position · 903,379 shares now+493,109
- Man Group PLCexisting position · 398,144 shares now+362,905
- AllianceBernstein LPexisting position · 299,077 shares now+235,257
Reductions
- AQR Capital Management LLCexisting position · 4,325,689 shares now-2,107,423
- Susquehanna International Group LLPexisting position · 320,505 shares now-577,027
- Renaissance Technologies LLCexisting position · 1,121,378 shares now-543,700
- Walleye Capital LLCexisting position · 34,421 shares now-254,111
- Balyasny Asset Management LLCexisting position · 152,280 shares now-239,764
New positions and exits
New (3)
Exited (5)
- Citadel Advisors LLCwas $14m
- D. E. Shaw & Co.was $10m
- Jane Street Group LLCwas $4.1m
- Winton Group Ltdwas $1.1m
- Neuberger Berman Group LLCwas $266k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 4 | $52m | n.a. | n.a. |
| Q3 2013 | 3 | $62m | n.a. | n.a. |
| Q4 2013 | 1 | $4.7m | n.a. | n.a. |
| Q1 2014 | 1 | $601k | n.a. | n.a. |
| Q2 2014 | 3 | $68m | n.a. | n.a. |
| Q3 2014 | 2 | $12m | n.a. | n.a. |
| Q4 2014 | 1 | $22m | n.a. | n.a. |
| Q1 2015 | 1 | $23m | n.a. | n.a. |
| Q2 2015 | 2 | $31m | n.a. | n.a. |
| Q3 2015 | 5 | $74m | n.a. | n.a. |
| Q4 2015 | 2 | $129m | n.a. | n.a. |
| Q1 2016 | 1 | $58m | n.a. | n.a. |
| Q2 2016 | 3 | $62m | n.a. | n.a. |
| Q3 2016 | 10 | $425m | n.a. | n.a. |
| Q4 2016 | 5 | $48m | n.a. | n.a. |
| Q1 2017 | 6 | $58m | n.a. | n.a. |
| Q2 2017 | 4 | $123m | n.a. | n.a. |
| Q3 2017 | 6 | $239m | n.a. | n.a. |
| Q4 2017 | 8 | $150m | n.a. | n.a. |
| Q1 2018 | 8 | $1.1bn | n.a. | n.a. |
| Q2 2018 | 20 | $2.6bn | n.a. | n.a. |
| Q3 2018 | 10 | $2.6bn | n.a. | n.a. |
| Q4 2018 | 13 | $2.1bn | n.a. | n.a. |
| Q1 2019 | 11 | $2.4bn | n.a. | n.a. |
| Q2 2019 | 11 | $2.9bn | n.a. | n.a. |
| Q3 2019 | 8 | $1.2bn | n.a. | n.a. |
| Q4 2019 | 9 | $2.5bn | n.a. | n.a. |
| Q1 2020 | 11 | $2.0bn | n.a. | n.a. |
| Q2 2020 | 16 | $3.6bn | n.a. | n.a. |
| Q3 2020 | 11 | $3.1bn | n.a. | n.a. |
| Q4 2020 | 13 | $4.0bn | n.a. | n.a. |
| Q1 2021 | 11 | $1.3bn | n.a. | n.a. |
| Q2 2021 | 9 | $1.0bn | n.a. | n.a. |
| Q3 2021 | 10 | $1.2bn | n.a. | n.a. |
| Q4 2021 | 13 | $1.2bn | n.a. | n.a. |
| Q1 2022 | 12 | $1.1bn | n.a. | n.a. |
| Q2 2022 | 13 | $946m | n.a. | n.a. |
| Q3 2022 | 21 | $1.8bn | n.a. | n.a. |
| Q4 2022 | 21 | $1.9bn | n.a. | n.a. |
| Q1 2023 | 20 | $2.3bn | n.a. | n.a. |
| Q2 2023 | 13 | $1.8bn | n.a. | n.a. |
| Q3 2023 | 19 | $2.1bn | n.a. | n.a. |
| Q4 2023 | 12 | $1.3bn | 6 | 10 |
| Q1 2024 | 15 | $2.0bn | 9 | 5 |
| Q2 2024 | 15 | $2.0bn | 8 | 9 |
| Q3 2024 | 12 | $1.4bn | 7 | 5 |
| Q4 2024 | 9 | $1.2bn | 4 | 5 |
| Q1 2025 | 11 | $665m | 9 | 3 |
| Q2 2025 | 5 | $175m | 5 | 1 |
| Q3 2025 | 6 | $164m | 2 | 3 |
| Q4 2025 | 7 | $298m | 16 | 15 |
| Q1 2026 | 5 | $281m | 18 | 11 |
| Q2 2026 | 5 | $132m | 14 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
SRPT and LLY →SRPT and JNJ →SRPT and VRTX →Choose a stock to compare with SRPT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own SRPT, latest filings →Back to the 13F Explorer →